Christopher Breuer, M.D. is a Professor of Surgery at The Ohio State University. He serves as the Director of the Regenerative Medicine and as Director of Surgical Research at Nationwide Children’s Hospital. Dr. Breuer runs a NIH funded laboratory that focuses on cardiovascular tissue engineering. His work is both basic and applied in nature. His basic science research is centered on investigating the cellular and molecular mechanisms underlying neotissue formation in cardiovascular tissue engineered constructs. His applied studies explore the use of tissue engineering technology for the development of improved vascular grafts and replacement heart valves for use in children. Dr Breuer served as the principal investigator on the first FDA-approved study evaluating the use of tissue engineered vascular grafts in humans. This study is evaluating the safety and growth potential of tissue engineered vascular graft in congenital heart surgery. He is currently beginning the next phase of this clinical trial.